Actinium-225 in Targeted Alpha Therapy
The utilization of actinium-225 (225Ac) radionuclides in targeted alpha therapy for cancer was initially outlined in 1993. Over the past two decades, substantial research has been conducted, encompassing the establishment of 225Ac production methods, various preclinical investigations, and several c...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2024-06-01
|
| Ráidu: | Journal of Medical Physics |
| Fáttát: | |
| Liŋkkat: | https://journals.lww.com/jomp/fulltext/2024/04000/actinium_225_in_targeted_alpha_therapy.2.aspx |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|